Post-earnings recap
Reported
Thu, Feb 5, 2009
EPS actual
$0.29
EPS est.
$0.80
EPS surprise
-63.75%
1-day move
+2.02%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
GSK's earnings report showed a significant miss on EPS, which could raise concerns among investors about profitability. However, the stock rose by 2.02%, likely driven by market optimism or other factors outside of the earnings results. The lack of revenue data and guidance leaves some uncertainty about the company's future performance.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.29 | N/A | -63.75% |
| Revenue | N/A | N/A | N/A |
Overall, management expressed a cautious outlook, recognizing the difficulties but remaining focused on future opportunities.
Management acknowledged the challenges faced during the quarter.
They emphasized a focus on long-term growth despite short-term setbacks.